KEGG   DISEASE: Huntington disease
Entry
H00059                      Disease                                
Name
Huntington disease
Description
Huntington disease (HD) is an autosomal-dominant neurodegenerative disorder that primarily affects medium spiny striatal neurons (MSN). The symptoms are choreiform, involuntary movements, personality changes and dementia. HD is caused by a CAG repeat expansion in the IT15 gene, which results in a long stretch of polyglutamine (polyQ) close to the amino-terminus of the HD protein huntingtin (Htt). Mutant Htt (mHtt) has effects both in the cytoplasm and in the nucleus. Full-length Htt is cleaved by proteases in the cytoplasm, leading to the formation of cytoplasmic and neuritic aggregates. mHtt also alters vesicular transport and recycling, causes cytosolic and mitochondrial Ca2+  overload, triggers endoplasmic reticulum stress through proteasomal dysfunction, and impairs autophagy function, increasing neuronal death susceptibility. N-terminal fragments containing the polyQ stretch translocate to the nucleus where they impair transcription and induce neuronal death.
Category
Neurodegenerative disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
 08 Diseases of the nervous system
  Movement disorders
   8A01  Choreiform disorders
    H00059  Huntington disease
Disease
pathway
hsa05016  Huntington disease
Network
nt06461 Huntington disease
nt06466 Pathways of neurodegeneration
Gene
(HD) HTT (CAG repeat expansion) [HSA:3064] [KO:K04533]
Drug
Tetrabenazine [DR:D08575]
Deutetrabenazine [DR:D10701]
Comment
Disease class: polyglutamine disease
Affected region: caudate nucleus, globus pallidus, thalamus, hippocampus
Microscopic lesion: neuronal intranuclear inclusions
Other DBs
ICD-11: 8A01.10
ICD-10: G10
MeSH: D006816
OMIM: 143100
Reference
  Authors
Imarisio S, Carmichael J, Korolchuk V, Chen CW, Saiki S, Rose C, Krishna G, Davies JE, Ttofi E, Underwood BR, Rubinsztein DC
  Title
Huntington's disease: from pathology and genetics to potential therapies.
  Journal
Biochem J 412:191-209 (2008)
DOI:10.1042/BJ20071619
Reference
  Authors
Spires TL, Hannan AJ
  Title
Molecular mechanisms mediating pathological plasticity in Huntington's disease and Alzheimer's disease.
  Journal
J Neurochem 100:874-82 (2007)
DOI:10.1111/j.1471-4159.2006.04275.x
Reference
  Authors
Gusella JF, Macdonald ME
  Title
Huntington's disease: seeing the pathogenic process through a genetic lens.
  Journal
Trends Biochem Sci 31:533-40 (2006)
DOI:10.1016/j.tibs.2006.06.009
Reference
  Authors
Gardian G, Vecsei L.
  Title
Huntington's disease: pathomechanism and therapeutic perspectives.
  Journal
J Neural Transm 111:1485-94 (2004)
DOI:10.1007/s00702-004-0201-4
Reference
PMID:8458085 (HD)
  Title
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.
  Journal
Cell 72:971-83 (1993)
DOI:10.1016/0092-8674(93)90585-e
LinkDB

» Japanese version

DBGET integrated database retrieval system